AAAAAA

   
Results: 1-25 | 26-41 |
Results: 26-41/41
Response of foot-and-mouth disease virus to increased mutagenesis: Influence of viral load and fitness in loss of infectivity
Authors: Sierra, S Davila, M Lowenstein, PR Domingo, E
Citation: S. Sierra et al., Response of foot-and-mouth disease virus to increased mutagenesis: Influence of viral load and fitness in loss of infectivity, J VIROLOGY, 74(18), 2000, pp. 8316-8323
Tolerance to cardiac allografts via local and systemic mechanisms after adenovirus-mediated CTLA4Ig expression
Authors: Guillot, C Mathieu, P Coathalem, H Le Mauff, B Castro, MG Tesson, L Usal, C Laumonier, T Brouard, S Soulillou, JP Lowenstein, PR Cuturi, MC Anegon, I
Citation: C. Guillot et al., Tolerance to cardiac allografts via local and systemic mechanisms after adenovirus-mediated CTLA4Ig expression, J IMMUNOL, 164(10), 2000, pp. 5258-5268
Viral vectors for gene delivery and gene therapy within the endocrine system
Authors: Stone, D David, A Bolognani, F Lowenstein, PR Castro, MG
Citation: D. Stone et al., Viral vectors for gene delivery and gene therapy within the endocrine system, J ENDOCR, 164(2), 2000, pp. 103-118
Adenovirus-mediated herpes simplex virus type-1 thymidine kinase gene therapy suppresses oestrogen-induced pituitary prolactinomas
Authors: Windeatt, S Southgate, TD Dewey, RA Bolognani, F Perone, MJ Larregina, AT Maleniak, TC Morris, ID Goya, RG Klatzmann, D Lowenstein, PR Castro, MG
Citation: S. Windeatt et al., Adenovirus-mediated herpes simplex virus type-1 thymidine kinase gene therapy suppresses oestrogen-induced pituitary prolactinomas, J CLIN END, 85(3), 2000, pp. 1296-1305
Transcriptional targeting to anterior pituitary lactotrophic cells using recombinant adenovirus vectors in vitro and in vivo in normal and estrogen/sulpiride-induced hyperplasic anterior pituitaries
Authors: Southgate, TD Windeatt, S Smith-Arica, J Gerdes, CA Perone, MJ Morris, I Davis, JRE Klatzmann, D Lowenstein, PR Castro, MG
Citation: Td. Southgate et al., Transcriptional targeting to anterior pituitary lactotrophic cells using recombinant adenovirus vectors in vitro and in vivo in normal and estrogen/sulpiride-induced hyperplasic anterior pituitaries, ENDOCRINOL, 141(9), 2000, pp. 3493-3505
Recent developments in gene therapy: applications for the treatment of pituitary tumours
Authors: Castro, MG Davis, JRE Xiong, WD Lowenstein, PR
Citation: Mg. Castro et al., Recent developments in gene therapy: applications for the treatment of pituitary tumours, BEST PRAC R, 13(3), 1999, pp. 431-449
Gene therapy for pituitary tumours
Authors: Davis, JRE Lowenstein, PR McNeilly, AS Castro, MG
Citation: Jre. Davis et al., Gene therapy for pituitary tumours, ENDOCR-R CA, 6(4), 1999, pp. 475-481
Chronic brain inflammation and persistent herpes simplex virus 1 thymidinekinase expression in survivors of syngeneic glioma treated by adenovirus-mediated gene therapy: Implications for clinical trials
Authors: Dewey, RA Morrissey, G Cowsill, CM Stone, D Bolognani, F Dodd, NJF Southgate, TD Klatzmann, D Lassmann, H Castro, MG Lowenstein, PR
Citation: Ra. Dewey et al., Chronic brain inflammation and persistent herpes simplex virus 1 thymidinekinase expression in survivors of syngeneic glioma treated by adenovirus-mediated gene therapy: Implications for clinical trials, NAT MED, 5(11), 1999, pp. 1256-1263
Treatment of experimental glioma by administration of adenoviral vectors expressing Fas ligand
Authors: Ambar, BB Frei, K Malipiero, U Morelli, AE Castro, MG Lowenstein, PR Fontana, A
Citation: Bb. Ambar et al., Treatment of experimental glioma by administration of adenoviral vectors expressing Fas ligand, HUM GENE TH, 10(10), 1999, pp. 1641-1648
Politically correct gene therapy? A "clean environment" improves gene delivery to the brain!
Authors: Lowenstein, PR Thomas, CE Castro, MG
Citation: Pr. Lowenstein et al., Politically correct gene therapy? A "clean environment" improves gene delivery to the brain!, GENE THER, 6(4), 1999, pp. 463-464
Adenoviruses encoding HPRT correct biochemical abnormalities of HPRT-deficient cells and allow their survival in negative selection medium
Authors: Southgate, TD Bain, D Fairbanks, LD Morelli, AE Larregina, AT Simmonds, HA Castro, MG Lowenstein, PR
Citation: Td. Southgate et al., Adenoviruses encoding HPRT correct biochemical abnormalities of HPRT-deficient cells and allow their survival in negative selection medium, METAB BRAIN, 14(4), 1999, pp. 205-221
Cell-type specific expression in the pituitary: physiology and gene therapy
Authors: Castro, MG Windeatt, S Smith-Arica, J Lowenstein, PR
Citation: Mg. Castro et al., Cell-type specific expression in the pituitary: physiology and gene therapy, BIOCH SOC T, 27, 1999, pp. 858-863
The basic science of brain-tumour gene therapy
Authors: Lowenstein, PR Cowen, R Thomas, C Castro, MG
Citation: Pr. Lowenstein et al., The basic science of brain-tumour gene therapy, BIOCH SOC T, 27, 1999, pp. 873-881
Interleukin-1 mediates a rapid inflammatory response after injection of adenoviral vectors into the brain
Authors: Cartmell, T Southgate, T Rees, GS Castro, MG Lowenstein, PR Luheshi, GN
Citation: T. Cartmell et al., Interleukin-1 mediates a rapid inflammatory response after injection of adenoviral vectors into the brain, J NEUROSC, 19(4), 1999, pp. 1517-1523
Generation of a recombinant herpes simplex virus type 1 expressing the ratcorticotropin-releasing hormone precursor: Endoproteolytic processing, intracellular targeting and biological activity
Authors: Tomasec, P Preston, CM Linton, EA Ahmed, I Lowenstein, PR Castro, MG
Citation: P. Tomasec et al., Generation of a recombinant herpes simplex virus type 1 expressing the ratcorticotropin-releasing hormone precursor: Endoproteolytic processing, intracellular targeting and biological activity, NEUROENDOCR, 70(6), 1999, pp. 439-450
Neuronal and glial cell type-specific promoters within adenovirus recombinants restrict the expression of the apoptosis-inducing molecule Fas ligand to predetermined brain cell types, and abolish peripheral liver toxicity
Authors: Morelli, AE Larregina, AT Smith-Arica, J Dewey, RA Southgate, TD Ambar, B Fontana, A Castro, MG Lowenstein, PR
Citation: Ae. Morelli et al., Neuronal and glial cell type-specific promoters within adenovirus recombinants restrict the expression of the apoptosis-inducing molecule Fas ligand to predetermined brain cell types, and abolish peripheral liver toxicity, J GEN VIROL, 80, 1999, pp. 571-583
Risultati: 1-25 | 26-41 |